We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
-1.54%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$96.4B
AUM Growth
-$1.4B
(-1.4%)
Cap. Flow
+$1.2B
Cap. Flow
% of AUM
1.25%
Top 10 Holdings %
Top 10 Hldgs %
33.93%
Holding
280
New
10
Increased
138
Reduced
66
Closed
10
Avg Time Held
2.2
years
Top 10 Avg Time Held
2.4
years
Top 20 Avg Time Held
1.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$363M |
| 2 |
JPMorgan Chase
JPM
|
+$363M |
| 3 |
American Airlines Group
AAL
|
+$310M |
| 4 |
CarMax
KMX
|
+$258M |
| 5 |
FedEx
FDX
|
+$191M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$779M |
| 2 |
DYAX
DYAX CORPORATION
DYAX
|
+$394M |
| 3 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$213M |
| 4 |
Bath & Body Works
BBWI
|
+$134M |
| 5 |
GSK
GSK
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.64% |
| 2 | Healthcare | 23.8% |
| 3 | Industrials | 15.3% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Financials | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Insulet
PODD
$9.62B
| $172M | 0.18% |
5,194,369
-1,300
| -0% | -$40.8K |
2013 Q2
11 quarters
|
|
102
Transocean
RIG
$6.15B
| $160M | 0.17% |
17,491,136
-358,800
| -2% | -$3.57M |
2013 Q2
11 quarters
|
|
103
Merck
MRK
$358B
| $158M | 0.16% |
3,136,454
+212,534
| +7% | +$10.4M |
2014 Q4
5 quarters
|
|
|
AFFX
104
DELISTED
Affymetrix Inc
AFFX
| $148M | 0.15% |
10,544,194
-353,546
| -3% | -$4.84M |
2013 Q2
11 quarters
|
|
105
DELISTED
Discover Financial Services
DFS
| $145M | 0.15% |
2,856,600
+367,100
| +15% | +$17.7M |
2014 Q1
8 quarters
|
|
106
C.H. Robinson
CHRW
$16.8B
| $136M | 0.14% |
1,832,654
-326,200
| -15% | -$22.4M |
2013 Q2
11 quarters
|
|
107
RTX Corp
RTX
$252B
| $131M | 0.14% |
2,075,075
+3,972
| +0.2% | +$230K |
2013 Q4
9 quarters
|
|
108
Applied Materials
AMAT
$341B
| $130M | 0.13% |
6,128,155
+45,400
| +0.7% | +$828K |
2013 Q2
11 quarters
|
|
109
Las Vegas Sands
LVS
$24.8B
| $129M | 0.13% |
2,502,481
+326,000
| +15% | +$14.9M |
2013 Q2
11 quarters
|
|
110
Rambus
RMBS
$10.1B
| $128M | 0.13% |
9,333,022
+8,700
| +0.1% | +$108K |
2013 Q2
11 quarters
|
|
111
Rockwell Automation
ROK
$46.9B
| $126M | 0.13% |
1,110,700
-447,240
| -29% | -$45.4M |
2013 Q2
11 quarters
|
|
112
Comscore
SCOR
$61.2M
| $126M | 0.13% |
209,627
+16,135
| +8% | +$11.7M |
2013 Q2
11 quarters
|
|
113
MarketAxess Holdings
MKTX
$5.79B
| $125M | 0.13% |
1,003,420
| – | – |
2013 Q2
11 quarters
|
|
114
CSX Corp
CSX
$90.2B
| $123M | 0.13% |
14,381,850
+685,050
| +5% | +$5.56M |
2013 Q2
11 quarters
|
|
115
Northern Trust
NTRS
$30.3B
| $116M | 0.12% |
+1,775,400
| New | +$111M |
2016 Q1
0 quarters
|
|
116
Apple
AAPL
$4.99T
| $113M | 0.12% |
4,162,000
-10,000
| -0.2% | -$249K |
2013 Q2
11 quarters
|
|
|
ASNA
117
DELISTED
Ascena Retail Group, Inc.
ASNA
| $113M | 0.12% |
512,105
+3,695
| +0.7% | +$652K |
2013 Q2
11 quarters
|
|
118
Tyson Foods
TSN
$19B
| $110M | 0.11% |
1,656,100
+16,100
| +1% | +$968K |
2014 Q4
5 quarters
|
|
119
DELISTED
Immunogen Inc
IMGN
| $110M | 0.11% |
12,867,483
| – | – |
2013 Q2
11 quarters
|
|
120
IDEX
IEX
$17.4B
| $109M | 0.11% |
1,319,810
+1,700
| +0.1% | +$127K |
2013 Q2
11 quarters
|
|
121
DELISTED
Electronic Arts
EA
| $108M | 0.11% |
1,638,825
-90,025
| -5% | -$5.74M |
2013 Q2
11 quarters
|
|
|
POT
122
DELISTED
Potash Corp Of Saskatchewan
POT
| $108M | 0.11% |
6,337,259
-726,074
| -10% | -$12.2M |
2013 Q2
11 quarters
|
|
123
Pentair
PNR
$8.53B
| $107M | 0.11% |
2,942,413
-342,470
| -10% | -$11.1M |
2013 Q2
11 quarters
|
|
|
ABAX
124
DELISTED
Abaxis Inc
ABAX
| $107M | 0.11% |
2,347,500
+1,500
| +0.1% | +$66.7K |
2013 Q4
9 quarters
|
|
125
Curtiss-Wright
CW
$18.5B
| $104M | 0.11% |
1,376,900
+72,250
| +6% | +$5.01M |
2013 Q3
10 quarters
|
|
Similar funds
Primecap Management's Q1 2016 Portfolio in Review
As of Q1 2016, Primecap Management held 280 positions worth $96.4B, down 1.4% from $97.8B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Primecap Management's Q1 2016 filing shows 10 new, 138 increased, 66 reduced and 10 closed positions. Its largest new stake was Northern Trust: 1,775,400 shares worth $116M. The largest sale was Johnson & Johnson, an estimated $779M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q1 2016 buy was Northern Trust: 1,775,400 shares worth $116M.
- Primecap Management added most to AstraZeneca in Q1 2016, an estimated $363M increase.
- Primecap Management's biggest Q1 2016 reduction was Johnson & Johnson, cutting an estimated $779M.
- Primecap Management fully exited DYAX CORPORATION in Q1 2016, selling an estimated $394M.
- Primecap Management's ten largest holdings make up 34% of its $96.4B portfolio in Q1 2016.
- Primecap Management opened 10 new positions and closed 10 in Q1 2016.
- Primecap Management's portfolio value fell 1.4% quarter-over-quarter to $96.4B.
Based on Primecap Management's 13F filing for Q1 2016, filed 12 May 2016.